Morning Market Movers
December 12, 2014 at 09:42 AM EST
ChemoCentryx (NASDAQ: CCXI) shares jumped 65.70% to $7.44 as primary endpoint achieved in Phase II CCX140 trial. Talisman Energy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.